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Abstract
Background: It is well known that maternal smoking during pregnancy and maternal pre-pregnancy overweight
have opposite effects on the infants’ birth weight. We report on the association of the combination between both
risk factors and the infants’ birth weight.
Methods: We studied 3241 infants born at term in the PIAMA birth cohort. Maternal smoking during pregnancy
and pre-pregnancy height and weight were self-reported. Multivariable regression analysis was performed to assess
the associations between infants of mothers who only smoked during pregnancy, who only had pre-pregnancy
overweight and who had both risk factors simultaneously, on term birth weight and the risk of being SGA or LGA.
Results: Of 3241 infants, 421 infants (13%) were born to smoking, non-overweight mothers, 514 (15.8%) to non-
smoking, overweight mothers, 129 (4%) to smoking and overweight mothers and 2177 (67%) to non-smoking, non-
overweight mothers (reference group). Infants of mothers who smoked and also had pre-pregnancy overweight
had similar term birth weight (− 26.6 g, 95%CI: − 113.0, 59.8), SGA risk (OR = 1.06, 95%CI: 0.56, 2.04), and LGA risk
(OR = 1.09, 95%CI: 0.61, 1.96) as the reference group.
Conclusions: Our findings suggested that the effects of maternal smoking during pregnancy and maternal pre-
pregnancy overweight on infants’ birth weight cancel each other out. Therefore, birth weight may not be a good
indicator of an infant’s health status in perinatal practice because it may mask potential health risks due to these
maternal risk factors when both present together.
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Background
Maternal smoking during pregnancy and pre-
pregnancy overweight are well-known examples of
obstetric risk factors that have an impact on infants’
health [1–5]. Infants of mothers who smoked during
pregnancy have on average a lower birth weight and
a greater risk of being small-for-gestational age
(SGA) than those born to non-smoking mothers [1,
2, 4, 6]. In contrast, infants of pre-pregnancy
overweight mothers have a higher birth weight and a
greater risk of being large-for-gestational age (LGA)
than those of normal-weight mothers [3, 5, 7, 8].
Relatively little is known about the combined effect of
maternal smoking during pregnancy and maternal pre-
pregnancy overweight on birth weight. The individual,
opposite effects of maternal smoking and maternal over-
weight may either cancel each other out resulting in nor-
mal birth weight as was observed in a recent large
population-based study [9], or the individual effect of
one maternal risk factor may prevail over the other as
was reported in a less recent, smaller study [10]. Birth
weight is often used as an indicator of the infant’s health
status which may not be valid for these common risk
factors with opposite effects.
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Therefore, the present study examined the combined
effect of maternal smoking during pregnancy and pre-
pregnancy overweight on term birth weight, the risk of
being born SGA or LGA in the PIAMA birth cohort, a
prospective birth cohort in the Netherlands.
Methods
Study design and setting
The present study is part of a population-based Dutch
birth cohort study: The Prevention and Incidence of
Asthma and Mite Allergy (PIAMA) Study. A detailed de-
scription of the study design has previously been pub-
lished [11]. In brief, mothers were recruited from the
general population during pregnancy and the children
were born in 1996–1997. The baseline population con-
sisted of 3963 children. The study protocol was ap-
proved by the medical ethics committees of the
participating institutes and all parents gave written in-
formed consent.
Study population
Of 3963 infants, we excluded 190 infants who were born
< 37 weeks of gestation as well as 33 infants with missing
information on gestational age. We additionally excluded
infants with missing values on maternal smoking during
pregnancy (n = 33), maternal pre-pregnancy overweight
(n = 451), and birth weight (n = 15) from the analysis.
Therefore, the population for analysis consisted of 3241
infants.
Data collection
In the PIAMA study, data were collected by self-
administered questionnaires which were sent to the par-
ents during pregnancy, at 3months after birth, yearly from
the child’s age of 1 to 8 years, and at 11, 14 and 17 years.
The present study used data collected during pregnancy,
at 3months after birth and at the child’s age of 1 and 2
years. Data on maternal smoking were collected during
pregnancy. Maternal age (years) and parity was assessed
by questionnaire at 3 months after the child’s birth. Data
on maternal educational level, weight and height before
pregnancy were collected in the 1-year questionnaire and
maternal ethnicity in the 2-year questionnaire.
Definition of variables
Exposures and outcomes
Maternal smoking during pregnancy was categorized
into smoking and non-smoking and refers to those who
reported smoking during at least the first 4 weeks of
pregnancy. This variable was created based on informa-
tion on current smoking during pregnancy and on infor-
mation on timing of quitting in mothers who reported
to be former smokers. Information on current smoking
status, smoking intensity and months since quitting was
assessed at the time of completing the ‘pregnancy ques-
tionnaire’: 95% of the ‘pregnancy’ questionnaires were
completed in the 3rd trimester of pregnancy (mean 33
wks; SD 3). Smoking intensity was asked only if mothers
were still smoking at the time of completion of the ques-
tionnaire, and represent only the number of cigarettes
they were smoking at that time. Maternal pre-pregnancy
body mass index (BMI) was calculated as body weight
(kg) divided by height squared (m2). We dichotomized
pre-pregnancy maternal BMI into overweight and obes-
ity (BMI ≥ 25 kg/m2) and non-overweight (BMI < 25 kg/
m2). With these two binary variables of maternal smok-
ing and maternal overweight, infants were classified into
four groups that will be referred to as: infants who were
born to (i) non-smoking, non-overweight (the reference
group), (ii) smoking, non-overweight, (iii) non-smoking
overweight, and (iv) smoking, overweight mothers.
The primary outcome was term birth weight (grams).
In the 3-months questionnaire, parents were asked to re-
port their infant’s birth weight and gestational age from
the delivery report. SGA was defined as infants with
birth weight below the 10th percentile for gestational
age, and LGA was defined as infants with birth weight
above the 90th percentile for gestational age according
to the standard national growth curve taking into ac-
count the infant’s sex and parity [12].
Covariates
Maternal age, ethnicity, educational level and parity
(parity for birth weight only) were considered as poten-
tial confounders which were set at priori based on litera-
ture [13]. Maternal ethnicity was classified according to
birth country as Dutch; western, non-Dutch (Europe
(except Turkey), North-America, Oceania, Indonesia,
Japan); and non-western (Africa, Latin-America, Asia
(except Indonesia, Japan), Turkey). Educational level was
categorized into three levels: low (primary schools, low
vocational training, or lower secondary education), inter-
mediate (intermediate vocational training, or intermedi-
ate/higher secondary education), and high (higher
vocational training or university degree). The presence
of older siblings was used as a proxy for parity and cate-
gorized into two groups: none and one or more. Gesta-
tional age was measured in weeks.
Statistical analysis
All statistical analyses were performed with Stata statis-
tical software version 12.1 (Stata Corporation, TX). Statis-
tical significance was defined by a two-sided alpha-level
p < 0.05. Baseline characteristics of study participants were
reported according to the four exposure categories. Differ-
ences in proportions for categorical variables were evalu-
ated using Chi square or Fisher’s exact tests. Means with
standard deviations were used to describe the distribution
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of continuous variables. One-way ANOVA with Bartlett’s
test for equal variances was used to test the difference in
means between exposure groups.
Multivariable linear regression analysis was performed
to examine the association of maternal smoking during
pregnancy, pre-pregnancy overweight, and the combin-
ation thereof on term birth weight. The beta-coefficients
represent the difference in term birth weight between in-
fants with the exposure of interest and the reference cat-
egory. Multivariable logistic regression analysis was used
to assess the associations of maternal risk factors with the
risk of being SGA or LGA. Associations are reported as
odds ratios (ORs) with 95% confidence intervals. All po-
tential confounders were included in the full model, then
backward elimination was performed to exclude non-
significant confounders one at a time until all variables in
the model had a p-value of < 0.20. This conservative level
was chosen to be sure that no confounders were missed.
Stratified and joint analyses
After assessing the main effects of maternal smoking
and maternal pre-pregnancy overweight, we performed
stratified analyses to assess the presence of effect modifi-
cation. We examined whether (1) the association be-
tween maternal smoking during pregnancy and infants’
term birth weight, and the risk of being SGA is modified
by maternal pre-pregnancy overweight, (2) the associ-
ation between maternal pre-pregnancy overweight and
birth weight, and the risk of being LGA is modified by
maternal smoking during pregnancy.
To assess the joint effect of maternal smoking during
pregnancy and maternal pre-pregnancy overweight with
95% confidence intervals, we used a 4-category exposure
variable (infants of non-smoking, non-overweight mothers,
smoking, non-overweight mothers, non-smoking, over-
weight mothers and smoking, overweight mothers) in the
regression models with adjustment for the same set of con-
founders using infants of non-smoking, non-overweight
mothers as the reference category. The presence of inter-
action was not tested statistically due to a lack of power.
Sensitivity analyses
We performed three types of sensitivity analyses and we
presented the results in the supplement. First, we per-
formed a sensitivity analysis to assess whether the sever-
ity of maternal pre-pregnancy overweight changed the
estimates and affected our interpretation. We therefore
repeated our analyses with three categories of maternal
weight: non-overweight, overweight (BMI 25–30 kg/m2),
and obese (BMI ≥ 30 kg/m2). Second, we performed a
sensitivity analysis taking smoking intensity into ac-
count. We expressed smoking intensity (number of ciga-
rettes per day) as a categorical variable. Infants of non-
smoking mothers formed the reference category, and
infants of smoking mothers were categorized in quartiles
of the numbers of cigarettes per day: > 0–2, 3–5, 6–10,
and > 10 cig/d. Information on smoking intensity was
available for mothers who were current smokers at the
time of filling in the ‘pregnancy questionnaire’ which
was in the 3rd trimester of pregnancy for 95% of the
mothers. Since we defined our maternal smoking vari-
able as smoking during ‘at least the first 4 weeks of preg-
nancy’, and since 22% of the smoking mothers had quit
by the time of filling the ‘pregnancy questionnaire’, we
have data on smoking intensity of 78% (429/550) of the
infants with smoking mothers. To compare the effect es-
timates of maternal smoking intensity on birth weight
with the effect estimates of the dichotomous smoking
variable on birth weight, we repeated the main analysis
(Table 2) using the study population excluding the 121
infants of smoking mothers without information on
smoking intensity. The third sensitivity analysis was per-
formed to explore the effect of adjustment for gesta-
tional weight gain (GWG) in the association under
study. We expressed GWG as a continuous variable (kg)
and as a categorical variable with cut-off points based on
the guideline of the US Institute of Medicine [14]: inad-
equate, adequate and excessive weight gain. We repeated
the main analysis additionally adjusted for GWG and
added the results of the joint effect in the supplementary
tables. Due to small numbers, we were not able to strat-
ify on GWG and disentangle the independent effect of
GWG and pre-pregnancy overweight.
Results
Characteristics of the study population
Of 3241 infants born at term, 421 infants (13%) were
born to smoking, non-overweight mothers, 514 (15.8%)
to non-smoking, overweight mothers, 129 (4%) to smok-
ing and overweight mothers. The reference group con-
sisted of 2177 (67.2%) infants who were born to non-
smoking, non-overweight mothers. The characteristics of
the study population are described according to these
categories in Table 1.
In infants of mothers who smoked during pregnancy
(irrespective of pre-pregnancy overweight) the mothers
more often were younger than 25 years, compared to the
reference group (9.8 and 10.2% versus 4.9% respectively).
In infants of mothers who smoked and also had pre-
pregnancy overweight, the mothers more often had a
low educational level.
Association of maternal smoking during pregnancy with
term birth weight and SGA in strata of maternal pre-
pregnancy overweight
In the overall analysis on the association of maternal
smoking during pregnancy with birth weight and SGA,
infants of smoking mothers had a lower term birth
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Table 1 Characteristics of the study population by category of maternal exposure
Characteristics All
(n =
3241)
Non-smoking mothers Smoking mothers
Non-overweight mothers (N =
2177)
Overweight mothers
(N = 514)
Non-overweight mothers
(N = 421)
Overweight mothers
(N = 129)
% (n) % (n) % (n) % (n) % (n)
Maternal age (years)*
< 25 5.7 (185) 4.9 (106) 4.9 (25) 9.8 (41) 10.2 (13)
25–34 79.5
(2566)
79.5 (1725) 83.2 (425) 75.4 (316) 78.1 (100)
≥ 35 14.8
(478)
15.6 (340) 11.9 (61) 14.8 (62) 11.7 (15)
Mean (SD) 30.5 (3.8) 30.7 (3.7) 30.0 (3.8) 30.0 (4.2) 29.5 (3.9)
Maternal ethnicity
Dutch 95.8
(3004)
95.7 (2022) 96.0 (486) 96.0 (384) 94.1 (112)
Western, non-
Dutch
2.6 (82) 2.8 (59) 1.8 (9) 2.3 (9) 4.2 (5)
Non-western 1.6 (51) 1.5 (31) 2.2 (11) 1.7 (7) 1.7 (2)
Education level*
Low 21.8
(707)
16.3 (355) 27.6 (142) 34.4 (144) 51.2 (66)
Intermediate 41.6
(1347)
41.3 (898) 45.4 (233) 40.1 (168) 37.2 (48)
High 36.6
(1183)
42.4 (922) 27.0 (139) 25.5 (107) 11.6 (15)
Presence of older siblings
None 48.6
(1575)
49.1 (1069) 47.9 (246) 47.7 (201) 45.7 (59)
1 or more 51.4
(1666)
50.9 (1108) 52.1 (268) 52.3 (220) 54.3 (70)
Gestational weight gain (kg)**
Mean (SD) 13.8 (4.9) 13.7 (4.4) 12.9 (5.5) 15.5 (5.6) 13.3 (7.5)
Birth weight (g)**
Mean (SD) 3560
(482)
3567 (469) 3678 (472) 3390 (500) 3521 (524)
SGA*
Yes 7.7 (248) 7.2 (157) 4.3 (22) 13.9 (58) 8.7 (11)
No 92.3
(2978)
92.8 (2011) 95.7 (491) 86.1 (360) 91.3 (116)
LGA*
Yes 11.3
(364)
10.5 (228) 17.4 (89) 7.9 (33) 11.0 (14)
No 88.7
(2862)
89.5 (1940) 82.6 (424) 92.1 (385) 89.0 (113)
Child’s gender
Girl 48.5
(1573)
48.1 (1048) 47.9 (246) 52.5 (221) 45.0 (58)
Boy 51.5
(1668)
51.9 (1129) 52.1 (268) 47.5 (200) 55.0 (71)
Abbreviations SGA Small for gestational age, LGA Large for gestational age
* P-value < 0.05 by Fisher’s exact test
** P-value < 0.05 by oneway ANOVA
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weight than those of non-smoking mothers, with an ad-
justed mean difference in birth weight of − 158.4 g
(95%CI: − 203.4, − 113.4). The lower birth weight was of
similar magnitude in both strata of maternal pre-
pregnancy overweight with an adjusted mean difference
in birth weight of − 164.5 g (95%CI: − 215.2, − 113.8) in
the stratum without maternal pre-pregnancy overweight
and − 145.2 g (95%CI: − 241.1, − 49.3) in the stratum
with maternal pre-pregnancy overweight (Table 2).
In the overall analysis on SGA, infants of smoking
mothers had a higher risk of being born SGA (adjusted
OR = 1.92, 95%CI: 1.42, 2.60) than those of non-smoking
mothers. The greater risk of being SGA in infants from
smoking versus non-smoking mothers was of similar mag-
nitude in both strata of maternal pre-pregnancy over-
weight with an adjusted OR of 1.96 (95%CI: 1.41, 2.72) in
the stratum without pre-pregnancy overweight and 1.89
(95%CI: 0.87, 4.09) in the stratum with pre-pregnancy
overweight (Table 2).
Association of maternal pre-pregnancy overweight with
term birth weight and LGA in strata of maternal smoking
during pregnancy
In the overall analysis of the association of maternal pre-
pregnancy overweight on birth weight and LGA, infants
of pre-pregnancy overweight mothers had a higher term
birth weight than those of non-overweight mothers, with
an adjusted mean difference in birth weight of 121.8 g
(95%CI: 79.7, 163.9). The higher birth weight was of
similar magnitude in both strata of maternal smoking
during pregnancy with an adjusted mean difference in
birth weight of 118.2 g (95%CI: 72.3, 164.1) in the
stratum without maternal smoking and 147.7 g (95%CI:
45.7, 249.7) in the stratum with maternal smoking
(Table 3).
In the overall analysis on LGA, infants of pre-
pregnancy overweight mothers had a greater risk of be-
ing born LGA (adjusted OR = 1.75, 95%CI: 1.36, 2.25)
than those of non-overweight mothers. The greater risk
of being LGA in infants from overweight versus non-
overweight mothers was of similar magnitude in both
strata of maternal smoking during pregnancy where an
adjusted OR was 1.79 (95%CI: 1.37, 2.35) in the stratum
without maternal smoking and 1.61 (95%CI: 0.75, 2.79)
in the stratum with maternal smoking (Table 3).
Combination of maternal smoking during pregnancy and
pre-pregnancy overweight on term birth weight, SGA and
LGA
To study the joint effect of maternal smoking and ma-
ternal pre-pregnancy overweight on birth weight and
SGA or LGA, we focused on infants of mothers with
both risk factors (those who smoked during pregnancy
and also had pre-pregnancy overweight) using infants of
non-smoking, non-overweight mothers as a reference
group. Infants of mothers with both risk factors had a
similar term birth weight with an adjusted mean differ-
ence of − 26.6 g (95%CI: − 113, 59.8) and a similar risk of
being SGA (adjusted OR = 1.06, 95%CI: 0.56, 2.04), and
LGA (adjusted OR = 1.09, 95%CI: 0.61, 1.96) as infants
of mothers without both risk factors (Table 4).
Sensitivity analysis
In the first sensitivity analysis with three strata of ma-
ternal pre-pregnancy BMI (non-overweight, overweight,
obese), the lower term birth weight (− 163.2 g, 95%CI:
− 394.1, 67.7) and increased risk of being SGA (OR =
Table 2 Associations of maternal smoking during pregnancy with term birth weight and the risk of being SGA: overall and in strata
of maternal pre-pregnancy overweight
Birth weight (g) SGA
Crude Diff (g)
(95% CI)
Adjusted Diff a (g)
(95% CI)
SGA/Total
(%)
Crude OR
(95% CI)
Adjusted OR b
(95% CI)
Main effect
Non-smoking 0 (Ref) 0 (Ref) 179/2681 (6.7%) 1.0 (Ref) 1.0 (Ref)
Smoking − 167.6 (− 211.5, − 123.7) −158.4 (−203.4, −113.4) 69/545 (12.7%) 2.02 (1.51, 2.72) 1.92 (1.42, 2.60)
Strata of maternal pre-pregnancy overweight:
Non-overweight
Non-smoking 0 (Ref) 0 (Ref) 157/2168 (7.2%) 1.0 (Ref) 1.0 (Ref)
Smoking −177.1 (− 226.6, − 127.6) −164.5 (−215.2, −113.8) 58/418 (13.9%) 2.06 (1.49, 2.85) 1.96 (1.41, 2.72)
Overweight
Non-smoking 0 (Ref) 0 (Ref) 22/513 (4.3%) 1.0 (Ref) 1.0 (Ref)
Smoking − 156.9 (− 250.4, −63.5) −145.2 (−241.1, −49.3) 11/127 (8.6%) 2.12 (0.99, 4.48) 1.89 (0.87, 4.09)
Abbreviations: Diff mean difference, SGA Small for gestational age, OR Odds ratio, CI Confidence interval
aMultivariable linear regression adjusted for maternal age and education
bMultivariable logistic regression adjusted for maternal age and education
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1.24, 95%CI: 0.26, 5.99) for infants of smoking mothers
was also observed in the stratum of obese mothers, and
these effects were not different for obese and over-
weight mothers (Supplementary Table S1). Also, the ef-
fects of maternal pre-pregnancy overweight and obesity
were similar in terms of term birth weight, and the risk
of being LGA by the strata of maternal smoking (Sup-
plementary Table S2). Infants of mothers who smoked
during pregnancy and were obese before pregnancy
had term birth weight (34.7 g, 95%CI: − 135.9, 205.3),
risk of being SGA (OR = 1.13, 95%CI: 0.33, 3.79) and
LGA (OR = 2.17, 95%CI: 0.87, 5.44) comparable to
those of mothers without these risk factors (Supple-
mentary Table S3). The second sensitivity analysis
showed that smoking intensity was somewhat higher in
overweight mothers than in non-overweight mothers
(Supplementary Table S4). In the overall analysis, and
in the stratum of mothers with normal pre-pregnancy
weight, infants of mothers who smoked more than 2
cig/d had a lower birth weight than those of non-
smoking mothers and mothers who smoked less than 2
cig/d (lowest smoking intensity). However, in the
stratum of overweight mothers, the lower birth weight
was observed only at the higher smoking intensity of 6
or more cig/day (Supplementary Table S5). Due to
small numbers, the confidence intervals around the
point estimates were wide and there was no clear dose-
response relationship of birth weight with smoking in-
tensity of > 2 cig/day. The third sensitivity analysis
(joint effect analysis in supplemental Table S6) suggests
that additional adjustment for GWG slightly increased
the effect estimates in the same direction as the main
analysis (Table 4). In infants of smoking, non-
overweight mothers, the effect on lower birth weight
and the higher risk of SGA was stronger; in infants of
non-smoking, overweight mothers, the effect on higher
birth weight and higher risk of LGA was stronger. The
combined effect of overweight and smoking became
slightly more attenuated to no difference in birth
weight and no increased risk of SGA and LGA.
Table 3 Associations of maternal pre-pregnancy overweight with term birth weight and the risk of being LGA; overall and in strata
of maternal smoking during pregnancy
Birth weight (g) LGA
Crude Diff
(95% CI)
Adjusted Diff a
(95% CI)
LGA/Total
(%)
Crude OR
(95% CI)
Adjusted OR b
(95% CI)
Main effect
Non-overweight 0 (Ref) 0 (Ref) 261/2325 (10.1%) 1.0 (Ref) 1.0 (Ref)
Overweight 107.6 (66.1, 149.1) 121.8 (79.7, 163.9) 103/537 (16.1%) 1.71 (1.34, 2.18) 1.75 (1.36, 2.25)
Strata maternal smoking during pregnancy
Non-smoking
Non-overweight 0 (Ref) 0 (Ref) 228/1940 (10.5%) 1.0 (Ref) 1.0 (Ref)
Overweight 110.4 (65.2, 155.6) 118.2 (72.3, 164.1) 89/424 (17.4%) 1.78 (1.37, 2.33) 1.79 (1.37, 2.35)
Smoking
Non-overweight 0 (Ref) 0 (Ref) 33/385 (7.9%) 1.0 (Ref) 1.0 (Ref)
Overweight 130.6 (30.6, 230.6) 147.7 (45.7, 249.7) 14/113 (11.0%) 1.44 (1.13, 4.88) 1.61 (0.75, 2.79)
Abbreviations: Diff mean difference, LGA Large for gestational age, OR Odds ratio, CI Confidence interval
aMultivariable linear regression adjusted for maternal age and education
bMultivariable logistic regression adjusted for maternal age and education
Table 4 The effects of the combinations of exposure to maternal smoking during pregnancy and pre-pregnancy overweight on
term birth weight and the risk of being SGA and LGA
Categories Birth weight (g) SGA LGA
Crude Diff (g)
(95% CI)
Adjusted Diff a (g)
(95% CI)
Crude OR
(95% CI)
Adjusted OR b
(95% CI)
Crude OR
(95% CI)
Adjusted OR c
(95% CI)
SM - OV- 0 (Ref) 0 (Ref) 1.0 (Ref) 1.0 (Ref) 1.0 (Ref) 1.0 (Ref)
SM+ OV- −177.1 (−226.8, −127.4) −163.8 (− 214.4, −113.1) 2.06 (1.49, 2.84) 1.94(1.39, 2.69) 0.73 (0.49, 1.07) 0.75 (0.51, 1.09)
SM - OV+ 110.4 (64.6, 156.2) 120.4 (74.1, 166.8) 0.57 (0.36, 0.90) 0.55 (0.34, 0.86) 1.79 (1.37, 2.33) 1.81 (1.38, 2.37)
SM+ OV+ −46.6(− 131.2, 38.1) −26.6(−113.0, 59.8) 1.21 (0.64, 2.30) 1.06 (0.56, 2.04) 1.05 (0.59, 1.87) 1.09 (0.61, 1.96)
Abbreviations: Diff mean Difference, SGA Small for gestational age, LGA Large for gestational age, OR Odds ratio, CI Confidence interval, SM maternal smoking
during pregnancy, OV maternal pre-pregnancy overweight
aMultivariable linear regression adjusted for maternal age and education
bMultivariable logistic regression adjusted for maternal age and education
cMultivariable logistic regression adjusted for maternal age and education
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Discussion
We found that infants of smoking, overweight mothers
had an average term birth weight and risk of being born
SGA or LGA which was comparable to that of infants of
mothers who did not smoke and had no pre-pregnancy
overweight. Since we also observed that maternal smok-
ing during pregnancy was significantly associated with a
lower term birth weight and a higher risk of being born
SGA; maternal pre-pregnancy overweight was signifi-
cantly associated with a higher term birth weight and a
higher risk of being born LGA. This indicates that the
effects of maternal smoking during pregnancy and of
maternal pre-pregnancy overweight on term birth weight
and the risk of SGA and LGA cancel each other out.
Methodological considerations
The large size of the study population allowed in-
fants to be cross-classified based on maternal smok-
ing and maternal overweight so that we could
examine the joint effect of both risk factors. The
PIAMA study is an unselected cohort, but due to
lower non-response and selective loss-to-follow-up,
infants of highly educated, more urban and allergic
mothers were overrepresented in the cohort. How-
ever, even if the distribution of pre-pregnancy over-
weight and smoking during pregnancy differs
between infants of high and low educated, urban and
rural or between allergic and non-allergic mothers
there is no firm ground to argue that the association
between exposure and birth weight also differs be-
tween these groups. Therefore the observed associ-
ation can be generalized to the general population of
infants of western origin. We also emphasize that
the results cannot be generalized towards children
who were born prematurely since we restricted our
analyses to infants born at full-term. The prevalence
of preterm births in the PIAMA study (4.2%) was
comparable to that in the general population (ap-
proximately 5–9%), [15] but it was too low to allow
for separate analyses within this group. Some meth-
odological limitations need to be considered. First,
we assessed smoking habits and pre-pregnancy BMI
status by self-reporting which could have introduced
bias if for example true smoking habits were under-
reported by smokers and BMI status (height and
weight) was underestimated by overweight women. It
is likely that this misclassification bias is random
and underestimates rather than overestimates the ob-
served effect size of each individual maternal risk
factor on birth weight, risk of SGA and LGA. Sec-
ond, the influences of unmeasured confounders such
as genetic and environmental factors cannot be ruled
out in the association under study. However, since
maternal smoking during pregnancy and pre-pre-
pregnancy overweight are known strong predictors
for infant’s birth weight, we assume that the contri-
bution of these confounders is trivial. Thirdly, miss-
ing pre-pregnancy BMI data could have attenuated
the effect size of maternal pre-pregnancy overweight
on birth weight and LGA risk. This holds true only
if the missingness is related to the outcome (i.e.
mothers who had heavy babies did not report their
pre-pregnancy BMI). However, we believe that the
missing BMI data would not largely bias our results
because it was not extensive (~ 11%; 451 of 3963)
and in addition the effect of maternal pre-pregnancy
overweight observed in our complete case analysis
are consistent to that reported in a recent systematic
review with the same interpretation [8]. A fourth
issue is the availability of more detailed information
on maternal smoking during pregnancy. In this
study, we investigated the effect of absence and pres-
ence of smoking during pregnancy as a dichotomous
variable but we realize that also the timing, duration
and intensity of smoking during pregnancy may de-
termine the effect on birth weight. We assessed ma-
ternal smoking at one point in time mostly in the
third trimester of pregnancy. However, due to the
relatively large range in the timing of filling in the
questionnaire, the information on the stage of smok-
ing, quitting and duration of smoking during preg-
nancy is not suitable for statistical analysis. Since
main analysis is based on smoking in ‘at least the
first 4 weeks of pregnancy’, infants of quitters during
pregnancy were also included in the analysis, which
is more likely to lead to underestimating than over-
estimating the effect of smoking. Sensitivity analyses
on the effect of smoking intensity showed that
mothers with pre-pregnancy overweight tended to
have a higher smoking intensity than non-overweight
mothers, but that the effect of smoking intensity on
a lower birth weight in their infants was smaller.
Our observation that the effects of maternal smoking
and overweight on birth weight cancel each other
out, may partly be due to this counterbalancing ef-
fect of smoking intensity. Thus, the net combined ef-
fect of smoking and overweight on birth weight,
SGA and LGA, may be slightly different depending
on smoking intensity in other study populations.
Studies with larger study populations are needed to
study the effect of intensity.
Comparison with previous studies
The main effects of maternal smoking during preg-
nancy (158.4 g lower birth weight and an almost
doubling of the risk of being born SGA compared to
infants of non-smoking mothers) and maternal pre-
pregnancy overweight (121.8 g higher birth weight
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and a 1.75 higher risk of being born LGA compared
to infants of non-overweight mothers) that we ob-
served in our study are consistent with findings re-
ported in the literature. Lower birth weight due to
maternal smoking in pregnancy may range from 150
to 300 g [2], and infants of smoking mothers have
about twice the risk of being born SGA compared to
those of non-smokers [16]. For maternal pre-
pregnancy overweight, a recent systematic review re-
ported that the ORs of being born LGA for infants
born to overweight and obese mothers were about
1.53 (95% CI: 1.44, 1.63) and 2.08 (95% CI: 1.95,
2.23) respectively [8]. Our first sensitivity analysis
shows that severity of maternal pre-pregnancy BMI
did not affect birth weight in infants of mothers with
both risk factors combined: these infants had similar
term birth weights as infants of mothers without
these risk factors. Our observation that the effects of
maternal smoking during pregnancy and maternal
pre-pregnancy overweight cancel each other out, is in
line with the results of a large population-based
study [9]. As argued above, the potential effect of
smoking intensity in the association needs further
study.
Biological mechanisms and health risks
The association of lower birth weight with maternal
smoking during pregnancy may be explained by many
potent constituents of cigarette smoke such as carbon
monoxide, polycyclic aromatic hydrocarbons and
nicotine [4, 6, 17]. These toxic substances not only
directly affect placental blood flow but cause the
fetus to absorb these substances leading to oxygen
deprivation in utero which is linked to intrauterine
growth restriction, birth weight loss, and being born
SGA [6, 17].
The association of higher birth weight with mater-
nal pre-pregnancy overweight may be explained by
maternal over-nutrition, although the exact mecha-
nisms remain unclear [3, 5, 18]. Growing evidence
suggests that maternal hyperglycemia is associated
with metabolic and hormonal disturbances, which
could result in rapid fetal growth in utero [5, 19].
For example, studies documented the link between
low levels of serum adiponectin in obese mothers
and increased fetal growth [20], as well as the link
between impaired placental regulations caused by ex-
cess free fatty acid and fat accumulation of the fetus
[21]. It is however evident that gestational weight
gain independently affects infants’ birth weight and
its relationship to maternal pre-pregnancy BMI is
complex because not only both are closely correlated
by nature (i.e. shared lifestyle factors, genetic traits)
[22–24]. Since GWG is partly on the causal pathway
between pre-pregnancy overweight and birth weight
and since we were not able to disentangle the inde-
pendent effects, we presented the main analysis with-
out additional adjustment for GWG. Additional
adjustment for GWG suggested that the effect of
smoking, non-overweight women was similar. The es-
timates of pre-pregnancy overweight and smoking
during pregnancy were somewhat stronger in the
same direction as the effect estimates in the main
analysis; the combined effect on birth weight was
slightly more attenuated towards no effect than in
the main analysis.
Study implication
The biological pathways of maternal smoking and ma-
ternal overweight on the fetus differ and our study
results do not suggest that these biological pathways
interfere when both risk factors are present in preg-
nant women. This indicates that the fetus may be at
risk of different adverse outcomes depending on
whether the exposure consists of maternal smoking or
maternal pre-pregnancy overweight because separate
pathways are involved in the exposure-outcome rela-
tionship. For example, sudden infant death syndrome
and stillbirth are attributed to maternal smoking [1,
2, 4] and congenital anomalies attributed to pre-
pregnancy overweight [3, 5]. Furthermore, both ma-
ternal risk factors put the fetus at higher risk of de-
veloping diseases later in life such as cardio-metabolic
diseases (i.e. overweight/obesity) in childhood as re-
ported by earlier studies [8, 19, 25–28]. Thus, further
investigation into the long term effects on child
health due to the combination of both maternal risk
factors is needed..
Our findings may have important implications for
perinatal practice. We observed that the effects of
maternal smoking during pregnancy and maternal
pre-pregnancy overweight on the infant’s term birth
weight cancel each other out, but the potential ad-
verse health effects during childhood are different for
each maternal risk factor and these may add up.
Since the infant’s birth weight is often used as a
health indicator in perinatal practice, this may mask
potential health risks over the life course.
Conclusion
Infants from mothers who smoked during pregnancy
and who also had pre-pregnancy overweight had a
similar term birth weight and similar risk of being
SGA and LGA as infants from mothers without these
risk factors. This indicates that the lower birth weight
associated with maternal smoking and the higher
birth weight associated with maternal pre-pregnancy
overweight cancel each other out.
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